508 related articles for article (PubMed ID: 30118822)
1. FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
Borm KJ; Voppichler J; Düsberg M; Oechsner M; Vag T; Weber W; Combs SE; Duma MN
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):574-582. PubMed ID: 30118822
[TBL] [Abstract][Full Text] [Related]
2. PET/CT in breast cancer staging is useful for evaluation of axillary lymph node and distant metastases.
Davidson T; Shehade N; Nissan E; Sklair-Levy M; Ben-Haim S; Barshack I; Zippel D; Halevy A; Chikman B
Surg Oncol; 2021 Sep; 38():101567. PubMed ID: 33866190
[TBL] [Abstract][Full Text] [Related]
3. Mapping of PET/CT-based regional nodes distribution of recurrent/advanced breast cancer and comparison with current delineation atlas.
Zhang M; Cao L; Chen J; Li B; Huang X; Cai G; Xu C
Br J Radiol; 2022 Sep; 95(1137):20220382. PubMed ID: 35731844
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
[TBL] [Abstract][Full Text] [Related]
5. Use of
Davidson T; Ben-David M; Galper S; Haskin T; Howes M; Scaife R; Kanana N; Amit U; Weizman N; Chikman B; Goshen E; Ben-Haim S; Symon Z; Goldstein J
Pract Radiat Oncol; 2017; 7(6):373-381. PubMed ID: 28989000
[TBL] [Abstract][Full Text] [Related]
6. Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design.
Borm KJ; Oechsner M; Düsberg M; Buschner G; Weber W; Combs SE; Duma MN
Radiother Oncol; 2020 Jan; 142():195-201. PubMed ID: 31540747
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the distribution of lymph node metastases compared to healthy lymph nodes in breast cancer.
Borm KJ; Ernst L; Voppichler J; Oechsner M; Düsberg M; Buschner G; Weber W; Combs SE; Duma MN
Radiat Oncol; 2022 Feb; 17(1):27. PubMed ID: 35123538
[TBL] [Abstract][Full Text] [Related]
8. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
Zhang X; Wu F; Han P
Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinically involved lymph nodes with deformable registration in breast cancer radiotherapy.
Turna M; Rzazade R; Canoğlu MD; Küçükmorkoç E; Küçük N; Çağlar HB
Br J Radiol; 2022 May; 95(1133):20211234. PubMed ID: 35084214
[TBL] [Abstract][Full Text] [Related]
10. Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.
Koolen BB; Valdés Olmos RA; Elkhuizen PH; Vogel WV; Vrancken Peeters MJ; Rodenhuis S; Rutgers EJ
Breast Cancer Res Treat; 2012 Aug; 135(1):231-40. PubMed ID: 22872522
[TBL] [Abstract][Full Text] [Related]
11. Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure.
van der Noordaa MEM; van Duijnhoven FH; Straver ME; Groen EJ; Stokkel M; Loo CE; Elkhuizen PHM; Russell NS; Vrancken Peeters MTFD
Ann Surg Oncol; 2018 Jun; 25(6):1512-1520. PubMed ID: 29511992
[TBL] [Abstract][Full Text] [Related]
12. Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Aukema TS; Straver ME; Peeters MJ; Russell NS; Gilhuijs KG; Vogel WV; Rutgers EJ; Olmos RA
Eur J Cancer; 2010 Dec; 46(18):3205-10. PubMed ID: 20719497
[TBL] [Abstract][Full Text] [Related]
13. Atlas of sentinel lymph nodes in early breast cancer using single-photon emission computed tomography: implication for lymphatic contouring.
Novikov SN; Krzhivitskii PI; Melnik YS; Valitova AA; Bryantseva ZV; Akulova IA; Kanaev SV
Radiat Oncol J; 2021 Mar; 39(1):8-14. PubMed ID: 33794569
[TBL] [Abstract][Full Text] [Related]
14. PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
Schiller K; Stöhrer L; Düsberg M; Borm K; Devecka M; Vogel MME; Tauber R; Heck MM; Rauscher I; Eiber M; Gschwend JE; Duma MN; Combs SE
Eur Urol Oncol; 2021 Feb; 4(1):73-83. PubMed ID: 32451312
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer staging in a single session: whole-body PET/CT mammography.
Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
[TBL] [Abstract][Full Text] [Related]
16. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
[TBL] [Abstract][Full Text] [Related]
17. An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
Keenan LG; Rock K; Azmi A; Salib O; Gillham C; McArdle O
Radiother Oncol; 2018 Jun; 127(3):417-422. PubMed ID: 29523410
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of PET/CT and VATS for detecting and treating internal mammary lymph node metastasis: a case series.
Kawaguchi S; Tamura N; Suzuki S; Nishikawa A; Shibata A; Tanaka K; Kobayashi Y; Ogura T; Sato J; Kinowaki K; Shiiba M; Ishihara M; Fujimori S; Kawabata H
Jpn J Clin Oncol; 2023 Jun; 53(7):562-571. PubMed ID: 37057634
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
Schirrmeister H; Kühn T; Guhlmann A; Santjohanser C; Hörster T; Nüssle K; Koretz K; Glatting G; Rieber A; Kreienberg R; Buck AC; Reske SN
Eur J Nucl Med; 2001 Mar; 28(3):351-8. PubMed ID: 11315604
[TBL] [Abstract][Full Text] [Related]
20. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
